Ubs Asset Management Americas Inc Teva Pharmaceutical Industries LTD Transaction History

Ubs Asset Management Americas Inc

$345 Billion
Q2 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,000,849 shares of TEVA stock, worth $17.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,000,849

Previous 2,223,464 54.99%

Holding current value

$17.5 Million

Previous $31.4 Million 48.16%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.78 - $17.4 $15.6 Million - $21.3 Million	-1,222,615 Reduced 54.99%	1,000,849 $16.3 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $421,315 - $569,782	-39,486 Reduced 1.74%	2,223,464 $31.4 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $222,496 - $291,272	-27,401 Reduced 1.2%	2,262,950 $23.6 Million
Q3 2023 Nov 13, 2023	BUY	$7.48 - $10.7 $2.78 Million - $3.98 Million	371,868 Added 19.38%	2,290,351 $23.4 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $736,323 - $1 Million	88,077 Added 4.81%	1,918,483 $17 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $1.22 Million - $1.45 Million	153,181 Added 9.13%	1,830,406 $16.7 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $881,612 - $1.54 Million	-128,515 Reduced 7.12%	1,677,225 $13.5 Million
Q2 2022 Aug 12, 2022	BUY	$7.38 - $10.4 $44,132 - $62,192	5,980 Added 0.33%	1,805,740 $13.6 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $664,940 - $851,813	-90,715 Reduced 4.8%	1,799,760 $16.9 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $184,583 - $238,089	-23,365 Reduced 1.22%	1,890,475 $15.1 Million
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $1.1 Million - $1.33 Million	130,872 Added 7.34%	1,913,840 $18.6 Million
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $879,684 - $1.03 Million	-88,857 Reduced 4.75%	1,782,968 $17.7 Million
Q1 2021 May 14, 2021	SELL	$10.34 - $12.81 $629,240 - $779,552	-60,855 Reduced 3.15%	1,871,825 $21.6 Million
Q4 2020 Mar 01, 2021	SELL	$8.61 - $11.04 $151,622 - $194,414	-17,610 Reduced 0.9%	1,932,680 $18.7 Million
Q3 2020 Nov 13, 2020	BUY	$8.57 - $12.69 $127,804 - $189,245	14,913 Added 0.77%	1,950,290 $17.6 Million
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $470,797 - $760,697	-57,980 Reduced 2.91%	1,935,377 $23.9 Million
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $613,105 - $1.23 Million	91,645 Added 4.82%	1,993,357 $17.9 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $1.16 Million - $1.9 Million	177,129 Added 10.27%	1,901,712 $18.6 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $1.17 Million - $1.82 Million	190,023 Added 12.38%	1,724,583 $11.9 Million
Q2 2019 Aug 15, 2019	SELL	$8.12 - $15.72 $2.46 Million - $4.76 Million	-302,680 Reduced 16.47%	1,534,560 $0
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $8.86 Million - $11.4 Million	-568,823 Reduced 23.64%	1,837,240 $0
Q4 2018 Feb 13, 2019	BUY	$14.59 - $23.84 $14.4 Million - $23.5 Million	984,975 Added 69.31%	2,406,063 $37.1 Million
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $276,370 - $336,604	-13,123 Reduced 0.91%	1,421,088 $0
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $862,447 - $1.27 Million	51,428 Added 3.72%	1,434,211 $0
Q1 2018 May 14, 2018	SELL	$16.68 - $22.07 $11,025 - $14,588	-661 Reduced 0.05%	1,382,783 $0
Q4 2017 Feb 09, 2018	BUY	$11.23 - $19.1 $156,433 - $266,063	13,930 Added 1.02%	1,383,444 $0
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $21.1 Million - $44.1 Million	1,369,514	1,369,514 $0

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Teva Pharmaceutical Industries LTD Transaction History